Clinical Trials In Lincoln

Discover hundreds of clinical trials in Lincoln.
Search clinical trials in Lincoln by condition or phase.

e.g. Respiratory Diseases

Lincoln•Healthy volunteers: No

Filter results

Results: 634

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Lincoln, Flagstaff, Glendale, Peoriashow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Lincoln, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Recruiting

Phase 3

Sponsor:

RayzeBio, Inc.

Location:

Omaha, Phoenix, Duarte, Irvineshow 25 more

Code:

NCT05477576

Conditions

GEP-NET

Gastroenteropancreatic Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor Disease

Neuroendocrine Tumors

Carcinoid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

Everolimus

Sunitinib

Octreotide

Lanreotide

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Recruiting

Sponsor:

IND Diagnostic Inc.

Location:

Bellevue, Franklin, Smyrna

Code:

NCT01491776

Conditions

Strep Throat

Eligibility Criteria

Sex: All

Age: 3+

Healthy Volunteers: Not accepted

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

United Therapeutics

Location:

Omaha, Birmingham, Jasper, Phoenixshow 75 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Recruiting

Phase 3

Sponsor:

Janssen Research & Development, LLC

Location:

Omaha, Little Rock, Los Alamitos, Los Angelesshow 27 more

Code:

NCT06319820

Conditions

Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAR-210

Gemcitabine

MMC

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Lincoln, Wahoo, Superior, St. Paulshow 940 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Lincoln, Papillion, Omaha, Kearneyshow 350 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bone Scan

Cabozantinib S-malate

Computed Tomography

Ipilimumab

Magnetic Resonance Imaging

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Recruiting

Phase 2

Phase 3

Sponsor:

Inhibrx Biosciences, Inc

Location:

Omaha, Duarte, Orange City, Bostonshow 2 more

Code:

NCT06295731

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INBRX-106

Pembrolizumab

Prospective Study of Pregnancy in Women With Cystic Fibrosis

Recruiting

Sponsor:

Amalia Magaret

Location:

Omaha, Birmingham, Little Rock, La Jollashow 35 more

Code:

NCT04828382

Conditions

Pregnancy Related

Cystic Fibrosis

Eligibility Criteria

Sex: Female

Age: 16+

Healthy Volunteers: Not accepted

e.g. Respiratory Diseases

Lincoln•Healthy volunteers: No

Filter results

Results: 634

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Lincoln, Flagstaff, Glendale, Peoriashow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Lincoln, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Recruiting

Phase 3

Sponsor:

RayzeBio, Inc.

Location:

Omaha, Phoenix, Duarte, Irvineshow 25 more

Code:

NCT05477576

Conditions

GEP-NET

Gastroenteropancreatic Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor Disease

Neuroendocrine Tumors

Carcinoid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

Everolimus

Sunitinib

Octreotide

Lanreotide

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Recruiting

Sponsor:

IND Diagnostic Inc.

Location:

Bellevue, Franklin, Smyrna

Code:

NCT01491776

Conditions

Strep Throat

Eligibility Criteria

Sex: All

Age: 3+

Healthy Volunteers: Not accepted

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

United Therapeutics

Location:

Omaha, Birmingham, Jasper, Phoenixshow 75 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Recruiting

Phase 3

Sponsor:

Janssen Research & Development, LLC

Location:

Omaha, Little Rock, Los Alamitos, Los Angelesshow 27 more

Code:

NCT06319820

Conditions

Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAR-210

Gemcitabine

MMC

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Lincoln, Wahoo, Superior, St. Paulshow 940 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

Phase 2

Sponsor:

National Cancer Institute (NCI)

Location:

Lincoln, Papillion, Omaha, Kearneyshow 350 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bone Scan

Cabozantinib S-malate

Computed Tomography

Ipilimumab

Magnetic Resonance Imaging

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Recruiting

Phase 2

Phase 3

Sponsor:

Inhibrx Biosciences, Inc

Location:

Omaha, Duarte, Orange City, Bostonshow 2 more

Code:

NCT06295731

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INBRX-106

Pembrolizumab

Prospective Study of Pregnancy in Women With Cystic Fibrosis

Recruiting

Sponsor:

Amalia Magaret

Location:

Omaha, Birmingham, Little Rock, La Jollashow 35 more

Code:

NCT04828382

Conditions

Pregnancy Related

Cystic Fibrosis

Eligibility Criteria

Sex: Female

Age: 16+

Healthy Volunteers: Not accepted